Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines

JAMA. 2021 Jun 1;325(21):2201-2202. doi: 10.1001/jama.2021.5374.
No abstract available

MeSH terms

  • Age Factors
  • Aged
  • COVID-19 / prevention & control
  • COVID-19 Vaccines / adverse effects*
  • Centers for Disease Control and Prevention, U.S.
  • Humans
  • Middle Aged
  • Population Surveillance
  • SARS-CoV-2 / genetics
  • United States
  • Vaccines, Synthetic / adverse effects

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic
  • mRNA Vaccine